Lynx1 Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-994,161
| Closed | -$14.8M | – | 18 |
|
|
2023
Q3 | $14.8M | Sell |
994,161
-210,889
| -18% | -$3.14M | 9.8% | 4 |
|
|
2023
Q2 | $13.2M | Sell |
1,205,050
-164,877
| -12% | -$1.81M | 8.65% | 4 |
|
|
2023
Q1 | $11.9M | Sell |
1,369,927
-283,568
| -17% | -$2.47M | 9.96% | 5 |
|
|
2022
Q4 | $10.4M | Sell |
1,653,495
-672,338
| -29% | -$4.22M | 8.97% | 5 |
|
|
2022
Q3 | $8.14M | Sell |
2,325,833
-263,846
| -10% | -$923K | 7.34% | 5 |
|
|
2022
Q2 | $7.64M | Buy |
2,589,679
+1,201,174
| +87% | +$3.54M | 6.51% | 5 |
|
|
2022
Q1 | $4.32M | Buy |
1,388,505
+163,537
| +13% | +$509K | 4.01% | 8 |
|
|
2021
Q4 | $4.14M | Buy |
+1,224,968
| New | +$4.14M | 3.61% | 8 |
|